CatSci Ltd, founded in 2010, is an award-winning innovation partner in the Biopharma, Biotechnology, Life Sciences, Manufacturing, and Pharmaceutical industries. Known for its excellence in medicines development, the company breaks down silos in small molecules, TACS, glues, and oligonucleotides CMC development. This allows them to accelerate the delivery of life-changing medicines from candidate selection to product launch and beyond.
Operating out of the United Kingdom, CatSci Ltd offers tailored services including route scouting, initial scale-up, and comprehensive process optimization for clinical and commercial manufacturing. A notable partnership with AGC Pharma Chemicals enhances their capability in scalable small molecule API manufacturing.
Recognized for Innovative Growth and ESG Excellence in numerous awards, their last investment was a £180.00K grant in early 2025 from UK Research and Innovation. With a technically adept team and advanced facilities, CatSci Ltd stands poised for further impact in the evolving healthcare sector.